Global Genomics Market Size, Share & Industry Trends Analysis Report By Product & Service, By Application, By End User, By Technology, By Regional Outlook, Strategy, Challenges and Forecast, 2021 - 2027

The Global Genomics Market size is expected to reach $68.9 billion by 2027, rising at a market growth of 17.5% CAGR during the forecast period.

A genome is an organism's genetic material. It includes genes, noncoding DNA, mitochondrial DNA, and chloroplast DNA, among other things. Genomic refers to the science and study of genomes. Because of its applicability in numerous fields of study, such as intragenomic phenomena such as epistasis, pleiotropy, heterosis, and other interactions between loci and alleles inside the genome, genomics is gaining massive traction in the market.

According to the National Cancer Institute, the number of new cancer cases would rise to 29.5 million by 2040, and the number of cancer-related fatalities will rise to 16.4 million per year. The requirement for vast amounts of DNA data to be stored, sequenced, and analyzed has opened the way for novel goods and software. In recent years, the aforementioned factors have played a crucial role in propelling the industry.

The increasing government funding for genomics projects, the rising incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups into the genomics market, and the growing application areas of genomics are the major factors driving the market's growth.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic has increased the burden on healthcare sector. The imposition of restrictions like complete or partial lockdown, temporary ban on manufacturing units and ban on imports & exports has negatively impacted various sectors of the business domain. The Covid-19 pandemic has drastically transformed the healthcare business as a whole, with the pandemic's effects felt in all areas of healthcare.

Both the government and commercial pharmaceutical and biotechnological businesses have intensified their research efforts and investments in order to create an effective or new COVID-19 treatment. The coronavirus genome sequence can be used to trace the spread of infection and its influence on the human genome. This information can subsequently be used to create an efficient infection treatment.

Market Growth Factors:

Innovative Product Launch and Technological Advancements

Several new products and services have emerged as a result of the trend toward individualized medications and lower sequencing costs due to the launch of NGS technology. With new competitors entering the market, the market is becoming increasingly competitive, and enterprises are responding by developing innovative products and services to strengthen their positions.

Adoption of genomics in specialized/personalized medicine

Personalized medicine research is becoming more popular among pharmaceutical corporations. Personalized medicine allows doctors to pinpoint a patient's specific needs and then prescribe medications and treatments to meet those needs. This method ensures improved treatment outcomes. In addition, advances in the field of gene therapy are projected to enable doctors to treat a problem by inserting a gene into a patient's cell, potentially replacing existing medications and operations.

Marketing Restraining Factor:

Growing concerns about Privacy

Genome sequencing not only offers information about the procedure's subject but also about those who are closely related to it. As a result, genomic data may have an impact on connections with other family members. Other family members may not want to know such details, or the client may choose to keep some information private. However, such knowledge may have significant ramifications for family members' well-being, and the client may be left with the difficult problem of determining what information to reveal and what information to keep hidden.

Product & Service Outlook

Based on the Product & Service, the Genomics Market is segregated into Systems & Software, Consumables, and Services. In 2020, the Consumables segment procured the maximum revenue share of the market. Consumables are widely utilized in genomic systems, and their use will continue to rise as the number of genetic tests performed around the world increases. The high-volume demand and usage of consumables, as well as the development of various new items in recent years, have all contributed to the growth of the segment. As the demand for new platforms to evaluate the massive amount of genetic data grows, new software and fully automated products are being developed.

Application Outlook

On the basis of Application, the Genomics Market is segregated into Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other Applications. In 2020, the Drug Discovery and Development segment emerged as the leading segment in the overall Genomics Market by procuring the maximum revenue share. This is due to the growing number of ongoing research and development activities on diseases like cancer and genetic disorders, as well as the reducing cost of sequencing.

End User Outlook

Based on End-User, the Genomics Market is divided into Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies, and others. In 2020, the Hospitals & Clinics segment procured the maximum revenue share of the market. This is due to the crucial role of genomics in Hospitals and genes. The genomics data can provide crucial insights into the medical condition of the patient. Moreover, the influx of the growing number of patients with chronic diseases in hospitals and clinics would further propel the growth of the segment during the forecasting period.

Technology Outlook

By Technology, the Genomics Market is segmented into Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, and Other Technologies. In 2020, the sequencing segment procured the highest revenue share of the overall Genomics market. The features of Sequencing technologies such as ultra-high throughput, scalability, and speed, enable researchers to perform a wide range of applications, including animal breeding, agriculture, and human genomics.

Genomics Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 21.9 Billion
Market size forecast in 2027	USD 68.9 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 17.5% from 2021 to 2027
Number of Pages	293
Number of Tables	481
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Product & Service, Application, Technology, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Innovative Product Launch and Technological Advancements  Adoption of genomics in specialized/personalized medicine
Restraints	Growing concerns about Privacy

Regional Outlook

By Region, the Genomics Market is analyzed across North America, Europe, APAC, and LAMEA. In 2020, North America emerged as the leading region in the overall Genomics Market. The major drivers of the North American market are increasing government initiatives to promote precision medicine, the adoption of different methods by important businesses to deliver effective genomics solutions in this region, and the presence of prominent players.

Free Valuable Insights: Global Genomics Market size to reach USD 68.9 Billion by 2027

KBV Cardinal Matrix - Genomics Market Competition Analysis

The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. Is the major forerunner in the Genomics Market. Companies such as Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., Danaher Corporation are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Eurofins Scientific Group, Qiagen N.V., and New England BioLabs, Inc.

Recent Strategies Deployed in Genomics Market

» Partnerships, Collaborations and Agreements:

• Dec-2021: Illumina formed a partnership with Gretel, a company that offers software solutions. Through this partnership, the two companies would together create Synthetic Data for Genomic Research. This partnership would give healthcare and life science practitioners artificial copies of complicated genomic datasets that are extremely statistically correct and compliant with GDPR, CCPA, and other significant privacy legislation. Moreover, researchers can acquire instant access to datasets by employing synthetic data, avoiding lengthy approval processes by institutional review boards (IRBs), which can take anywhere from 6 months to a year nowadays.
• Dec-2021: QIAGEN teamed up with Denovo Biopharma, a privately held biotech company providing a novel biomarker solution to personalize drug development. Following the collaboration, the two entities would together develop a blood-based companion diagnostic (CDx) test to identify patients expressing Denovo Genomic Marker 1 (DGM1TM). Moreover, QIAGEN would design a diagnostic assay that can identify the Denovo Genomic Marker 1 (DGM1TM) in DLBCL patients, a biomarker developed by Denovo that estimates the responsiveness to DB102.
• Sep-2021: Illumina came into a partnership with Myriad Genetics, a leading genetic testing, and precision medicine company. Through this partnership, the two companies would integrate diagnostics and next-generation sequencing to promote full genomic profiling of tumor samples and drive improved oncology outcomes. Moreover, Illumina would offer a kit-based version of the myChoice CDx test for the global markets.
• Jul-2021: QIAGEN came into a partnership with Sysmex Corporation, a world leader in clinical laboratory systemization and solutions. Under this partnership, the two companies would work on global cancer companion diagnostics development and commercialization with the help of NGS and Plasma-Safe-SeqS technology. Moreover, the partnership would further strengthen the partnerships with pharmaceutical companies to develop drug treatments for cancer and encourage early clinical adoption of ultra-sensitive liquid biopsy companion diagnostics.
• Jul-2021: Bio-Rad formed a partnership with Seegene, a Korean manufacturer of in vitro diagnostic products, particularly molecular diagnostics. Through this partnership, the two companies would explore Molecular Diagnostic Testing Products. Moreover, Seegene’s innovative assay design, chemistries, and high-level multiplexing can identify many infectious disease targets at the same time, making the assays suitable for syndromic testing.
• Jul-2020: Thermo Fisher Scientific partnered with First Genetics JCS. Following the partnership, the two companies would jointly develop advanced Sequencing-Based Diagnostics in Russia. The partnership would help First Genetics to market its F-Genetics NGS System and IVD assays across the Russian labs for the purpose of reproductive health testing and cancer diagnostics.
• Jan-2020: Roche formed a partnership with Illumina, a company that develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The partnership would increase patient access to genomic testing. The partnership aimed to integrate the extensive decentralized installed base of Illumina with Roche’s expertise in assay development and to offer broad access to clinical oncology next-generation sequencing.

» Acquisitions and Mergers:

• Dec-2021: Eurofins acquired Genetic Lab. Through this acquisition, the company would improve its Clinical and COVID-19 Testing Offering in Japan. Moreover, the acquisition aimed to expand the company's footprints in Asia and support its worldwide network of clinical diagnostics laboratories centered around specialized and advanced genetic testing.
• Sep-2021: Illumina completed the acquisition of GRAIL, an American biotechnology and pharmaceutical company. Through this acquisition, the company would introduce a New Era of Cancer Detection. Moreover, the company would accelerate the commercialization and adoption of a game-changing multi-cancer screening test that has the potential to detect more cancers earlier and improve outcomes. In addition, the company aimed to add a Multi-Disciplinary Team and Capabilities to Address One of Medicine's Greatest Challenges Using Next-Generation Sequencing (NGS), Population Scale Clinical Studies, and Machine Learning In the clinical setting.
• Jul-2020: Illumina acquired Enancio, a French startup that makes genomic-specific compression software. By compressing the output from Illumina's sequencers from 50GB to 10GB, Enancio's loss-less compression technology decreases data storage expenses by up to five times. Enancio's technology will be directly integrated into DRAGEN, as well as into the cloud storage platform offerings of Illumina.
• Jun-2020: Illumina took over BlueBee, a cloud-based software company that offers genomics analysis solutions for research and clinical customers. Through this acquisition, the company would expand its capabilities to examine and interpret the data generated by its sequencing systems. Moreover, users would be able to run their own custom analyses or use industry-leading choices like the DRAGENTM Bio-IT Platform due to the integration of BlueBee's capabilities into Illumina's cloud portfolio, speeding data processing and enhancing operational efficiency. 
• May-2020: Roche completed the acquisition of Stratos Genomics, a company that develops sequencing by expanding the single-molecule detection process that allows whole-genome sequencing. Through this acquisition, Roche would accelerate the development of its nanopore sequencer. Moreover, the acquisition offers Roche access to Stratos Genomics' unique chemistry, Sequencing by Expansion (SBX).
• Apr-2020: Bio-Rad took over, a Single-Cell Analysis Solutions Provider. In addition, Scientists can use the Genesis System to isolate, analyze, and interpret cellular behavior as well as collect cell-based data for better results in single-cell cytometry, single-cell transcriptomics, single-cell multiomics, rare-cell enrichment, enumeration, and immune monitoring, among other applications. Moreover, for genomic and proteomic applications, the system can scale from hundreds of thousands to millions of cells, and it can enrich or monitor circulating tumor cells to detect disease progression and therapy response. 

» Product Launches and Product Expansions:

• Oct-2021: Roche along with its subsidiary Foundation Medicine, introduced the AVENIO Tumor Tissue CGP Kit. This kit expanded the prevailing offering of Roche and Foundation Medicine and enables laboratories to expand their oncology research in-house.
• Oct-2021: Bio-Rad introduced its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics. In addition, for diagnostic testing and research, the systems provide accurate and exact quantification to boost assay development and workflow efficiencies, and productivity. Moreover, both systems are reliable and secure platforms that take advantage of Bio-Rad's experience with genomic technologies to address the needs of the research and clinical diagnostic sectors.
• Jun-2021: QIAGEN introduced CRISPR (clustered regularly interspaced short palindromic repeats Products) for Rapid and Simplified Analysis of Gene-Editing Experiments. Through this launch, the company would expand its product offerings of dedicated solutions which are suitable for the rapidly rising field of CRISPR technology utilized for editing genomes and modifying gene function. Moreover, CRISPR features a wide range of applications, from correcting genetic defects, treating and preventing the spread of diseases, and expediting drug discovery and biomedical research.
• Jun-2021: New England Biolabs introduced Primer Monitor Tool for Tracking SARS-CoV-2 Variants that could Impact Primers utilized in Diagnostic Assays. The Primer Monitor Tool, which is updated on a constant basis, provides a simple representation of known SARS-CoV-2 genome variants and provides insight into where commonly used or user-defined primer set evaluations may be beneficial. The tool is pre-loaded with SARS-CoV-2 qPCR and LAMP primer sequences, as well as ARTIC sequencing procedures (currently v3). Users can watch established primer sets as well as upload their own sequences of interest, with the ability to subscribe and be notified if fluctuation in a geographic region of interest exceeds a predetermined threshold. 
• May-2021: Bio-Rad unveiled the SEQuoia RiboDepletion Kit for Next-Generation Sequencing. With the help of this kit, genomics researchers can acquire the best quality sequencing data while enhancing efficiencies and saving costs.
• Apr-2021: Bio-Rad introduced ddPCR Assays for AAV Viral Titer and the Vericheck ddPCR Mycoplasma Detection Kit. Through this launch, the company expanded its offerings of Cell and Gene Therapy. These products would help in the development and manufacture of secure and efficient cell and gene therapies. Moreover, these products would help the company to fulfill the growing requirement for secure and effective therapeutics.
• Mar-2021: Roche introduced Cobas SARS-CoV-2 Variant Set 1 Test to assist the monitoring of new coronavirus mutations. Moreover, the test is developed to identify major spike mutations in virus variants related to increased human-to-human transmission. In addition, SARS-CoV-2 mutations can be accurately detected and differentiated, which can aid in assessing the distribution of circulating variants and monitoring their potential influence on treatments, vaccines, and public health initiatives.
• Feb-2021: New England Biolabs launched ARTIC Products for SARS-CoV-2 Sequencing. In addition, the new kits would enhance the well-formed ARTIC protocols for SARS-CoV-2 genome sequencing with optimized reagents and enhanced uniformity of coverage depth for Illumina and Oxford Nanopore Technologies advanced sequencing (NGS) platforms.
• Jan-2020: Agilent rolled out the advanced SureSelect DNA Kit. The new kit is developed to manage the major limitations faced by the labs when creating DNA sequencing libraries for their research. Moreover, the latest Agilent SureSelect XT HS2 DNA Kit features cutting-edge library preparation and target enrichment, providing researchers with a comprehensive solution that enables them to choose workflow options that fulfill their requirements.

Scope of the Study

Market Segments Covered in the Report:

By Product & Service

• Consumables
• Systems & Software and
• Services

By Application

• Drug Discovery & Development
• Diagnostics
• Agriculture & Animal Research and
• Others

By End User

• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Pharmaceutical & Biotechnology Companies and
• Others

By Technology

• Sequencing
• PCR
• Nucleic Acid Extraction & Purification
• Microarray, and
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Creative Biogene
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Agilent Technologies, Inc.
• Hoffmann-La Roche Ltd.
• Eurofins Scientific Group
• Qiagen N.V.
• New England BioLabs, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Genomics Market, by Product & Service
1.4.2 Global Genomics Market, by Application
1.4.3 Global Genomics Market, by End User
1.4.4 Global Genomics Market, by Technology
1.4.5 Global Genomics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, Dec) Leading Players

Chapter 4. Global Genomics Market by Product & Service
4.1 Global Consumables Market by Region
4.2 Global Systems & Software Market by Region
4.3 Global Services Market by Region

Chapter 5. Global Genomics Market by Application
5.1 Global Drug Discovery & Development Market by Region
5.2 Global Diagnostics Market by Region
5.3 Global Agriculture & Animal Research Market by Region
5.4 Global Others Market by Region

Chapter 6. Global Genomics Market by End User
6.1 Global Hospitals & Clinics Market by Region
6.2 Global Research Centers and Academic & Government Institutes Market by Region
6.3 Global Pharmaceutical & Biotechnology Companies Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Genomics Market by Technology
7.1 Global Sequencing Market by Region
7.2 Global PCR Market by Region
7.3 Global Nucleic Acid Extraction & Purification Market by Region
7.4 Global Microarray Market by Region
7.5 Global Others Market by Region

Chapter 8. Global Genomics Market by Region
8.1 North America Genomics Market
8.1.1 North America Genomics Market by Product & Service
8.1.1.1 North America Consumables Market by Country
8.1.1.2 North America Systems & Software Market by Country
8.1.1.3 North America Services Market by Country
8.1.2 North America Genomics Market by Application
8.1.2.1 North America Drug Discovery & Development Market by Country
8.1.2.2 North America Diagnostics Market by Country
8.1.2.3 North America Agriculture & Animal Research Market by Country
8.1.2.4 North America Others Market by Country
8.1.3 North America Genomics Market by End User
8.1.3.1 North America Hospitals & Clinics Market by Country
8.1.3.2 North America Research Centers and Academic & Government Institutes Market by Country
8.1.3.3 North America Pharmaceutical & Biotechnology Companies Market by Country
8.1.3.4 North America Others Market by Country
8.1.4 North America Genomics Market by Technology
8.1.4.1 North America Sequencing Market by Country
8.1.4.2 North America PCR Market by Country
8.1.4.3 North America Nucleic Acid Extraction & Purification Market by Country
8.1.4.4 North America Microarray Market by Country
8.1.4.5 North America Others Market by Country
8.1.5 North America Genomics Market by Country
8.1.5.1 US Genomics Market
8.1.5.1.1 US Genomics Market by Product & Service
8.1.5.1.2 US Genomics Market by Application
8.1.5.1.3 US Genomics Market by End User
8.1.5.1.4 US Genomics Market by Technology
8.1.5.2 Canada Genomics Market
8.1.5.2.1 Canada Genomics Market by Product & Service
8.1.5.2.2 Canada Genomics Market by Application
8.1.5.2.3 Canada Genomics Market by End User
8.1.5.2.4 Canada Genomics Market by Technology
8.1.5.3 Mexico Genomics Market
8.1.5.3.1 Mexico Genomics Market by Product & Service
8.1.5.3.2 Mexico Genomics Market by Application
8.1.5.3.3 Mexico Genomics Market by End User
8.1.5.3.4 Mexico Genomics Market by Technology
8.1.5.4 Rest of North America Genomics Market
8.1.5.4.1 Rest of North America Genomics Market by Product & Service
8.1.5.4.2 Rest of North America Genomics Market by Application
8.1.5.4.3 Rest of North America Genomics Market by End User
8.1.5.4.4 Rest of North America Genomics Market by Technology
8.2 Europe Genomics Market
8.2.1 Europe Genomics Market by Product & Service
8.2.1.1 Europe Consumables Market by Country
8.2.1.2 Europe Systems & Software Market by Country
8.2.1.3 Europe Services Market by Country
8.2.2 Europe Genomics Market by Application
8.2.2.1 Europe Drug Discovery & Development Market by Country
8.2.2.2 Europe Diagnostics Market by Country
8.2.2.3 Europe Agriculture & Animal Research Market by Country
8.2.2.4 Europe Others Market by Country
8.2.3 Europe Genomics Market by End User
8.2.3.1 Europe Hospitals & Clinics Market by Country
8.2.3.2 Europe Research Centers and Academic & Government Institutes Market by Country
8.2.3.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
8.2.3.4 Europe Others Market by Country
8.2.4 Europe Genomics Market by Technology
8.2.4.1 Europe Sequencing Market by Country
8.2.4.2 Europe PCR Market by Country
8.2.4.3 Europe Nucleic Acid Extraction & Purification Market by Country
8.2.4.4 Europe Microarray Market by Country
8.2.4.5 Europe Others Market by Country
8.2.5 Europe Genomics Market by Country
8.2.5.1 Germany Genomics Market
8.2.5.1.1 Germany Genomics Market by Product & Service
8.2.5.1.2 Germany Genomics Market by Application
8.2.5.1.3 Germany Genomics Market by End User
8.2.5.1.4 Germany Genomics Market by Technology
8.2.5.2 UK Genomics Market
8.2.5.2.1 UK Genomics Market by Product & Service
8.2.5.2.2 UK Genomics Market by Application
8.2.5.2.3 UK Genomics Market by End User
8.2.5.2.4 UK Genomics Market by Technology
8.2.5.3 France Genomics Market
8.2.5.3.1 France Genomics Market by Product & Service
8.2.5.3.2 France Genomics Market by Application
8.2.5.3.3 France Genomics Market by End User
8.2.5.3.4 France Genomics Market by Technology
8.2.5.4 Russia Genomics Market
8.2.5.4.1 Russia Genomics Market by Product & Service
8.2.5.4.2 Russia Genomics Market by Application
8.2.5.4.3 Russia Genomics Market by End User
8.2.5.4.4 Russia Genomics Market by Technology
8.2.5.5 Spain Genomics Market
8.2.5.5.1 Spain Genomics Market by Product & Service
8.2.5.5.2 Spain Genomics Market by Application
8.2.5.5.3 Spain Genomics Market by End User
8.2.5.5.4 Spain Genomics Market by Technology
8.2.5.6 Italy Genomics Market
8.2.5.6.1 Italy Genomics Market by Product & Service
8.2.5.6.2 Italy Genomics Market by Application
8.2.5.6.3 Italy Genomics Market by End User
8.2.5.6.4 Italy Genomics Market by Technology
8.2.5.7 Rest of Europe Genomics Market
8.2.5.7.1 Rest of Europe Genomics Market by Product & Service
8.2.5.7.2 Rest of Europe Genomics Market by Application
8.2.5.7.3 Rest of Europe Genomics Market by End User
8.2.5.7.4 Rest of Europe Genomics Market by Technology
8.3 Asia Pacific Genomics Market
8.3.1 Asia Pacific Genomics Market by Product & Service
8.3.1.1 Asia Pacific Consumables Market by Country
8.3.1.2 Asia Pacific Systems & Software Market by Country
8.3.1.3 Asia Pacific Services Market by Country
8.3.2 Asia Pacific Genomics Market by Application
8.3.2.1 Asia Pacific Drug Discovery & Development Market by Country
8.3.2.2 Asia Pacific Diagnostics Market by Country
8.3.2.3 Asia Pacific Agriculture & Animal Research Lumens Genomics Market by Country
8.3.2.4 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Genomics Market by End User
8.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
8.3.3.2 Asia Pacific Research Centers and Academic & Government Institutes Market by Country
8.3.3.3 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
8.3.3.4 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Genomics Market by Technology
8.3.4.1 Asia Pacific Sequencing Market by Country
8.3.4.2 Asia Pacific PCR Market by Country
8.3.4.3 Asia Pacific Nucleic Acid Extraction & Purification Market by Country
8.3.4.4 Asia Pacific Microarray Market by Country
8.3.4.5 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Genomics Market by Country
8.3.5.1 China Genomics Market
8.3.5.1.1 China Genomics Market by Product & Service
8.3.5.1.2 China Genomics Market by Application
8.3.5.1.3 China Genomics Market by End User
8.3.5.1.4 China Genomics Market by Technology
8.3.5.2 Japan Genomics Market
8.3.5.2.1 Japan Genomics Market by Product & Service
8.3.5.2.2 Japan Genomics Market by Application
8.3.5.2.3 Japan Genomics Market by End User
8.3.5.2.4 Japan Genomics Market by Technology
8.3.5.3 India Genomics Market
8.3.5.3.1 India Genomics Market by Product & Service
8.3.5.3.2 India Genomics Market by Application
8.3.5.3.3 India Genomics Market by End User
8.3.5.3.4 India Genomics Market by Technology
8.3.5.4 South Korea Genomics Market
8.3.5.4.1 South Korea Genomics Market by Product & Service
8.3.5.4.2 South Korea Genomics Market by Application
8.3.5.4.3 South Korea Genomics Market by End User
8.3.5.4.4 South Korea Genomics Market by Technology
8.3.5.5 Singapore Genomics Market
8.3.5.5.1 Singapore Genomics Market by Product & Service
8.3.5.5.2 Singapore Genomics Market by Application
8.3.5.5.3 Singapore Genomics Market by End User
8.3.5.5.4 Singapore Genomics Market by Technology
8.3.5.6 Malaysia Genomics Market
8.3.5.6.1 Malaysia Genomics Market by Product & Service
8.3.5.6.2 Malaysia Genomics Market by Application
8.3.5.6.3 Malaysia Genomics Market by End User
8.3.5.6.4 Malaysia Genomics Market by Technology
8.3.5.7 Rest of Asia Pacific Genomics Market
8.3.5.7.1 Rest of Asia Pacific Genomics Market by Product & Service
8.3.5.7.2 Rest of Asia Pacific Genomics Market by Application
8.3.5.7.3 Rest of Asia Pacific Genomics Market by End User
8.3.5.7.4 Rest of Asia Pacific Genomics Market by Technology
8.4 LAMEA Genomics Market
8.4.1 LAMEA Genomics Market by Product & Service
8.4.1.1 LAMEA Consumables Market by Country
8.4.1.2 LAMEA Systems & Software Market by Country
8.4.1.3 LAMEA Services Market by Country
8.4.2 LAMEA Genomics Market by Application
8.4.2.1 LAMEA Drug Discovery & Development Market by Country
8.4.2.2 LAMEA Diagnostics Market by Country
8.4.2.3 LAMEA Agriculture & Animal Research Market by Country
8.4.2.4 LAMEA Others Market by Country
8.4.3 LAMEA Genomics Market by End User
8.4.3.1 LAMEA Hospitals & Clinics Market by Country
8.4.3.2 LAMEA Research Centers and Academic & Government Institutes Market by Country
8.4.3.3 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
8.4.3.4 LAMEA Others Market by Country
8.4.4 LAMEA Genomics Market by Technology
8.4.4.1 LAMEA Sequencing Market by Country
8.4.4.2 LAMEA PCR Market by Country
8.4.4.3 LAMEA Nucleic Acid Extraction & Purification Market by Country
8.4.4.4 LAMEA Microarray Market by Country
8.4.4.5 LAMEA Others Market by Country
8.4.5 LAMEA Genomics Market by Country
8.4.5.1 Brazil Genomics Market
8.4.5.1.1 Brazil Genomics Market by Product & Service
8.4.5.1.2 Brazil Genomics Market by Application
8.4.5.1.3 Brazil Genomics Market by End User
8.4.5.1.4 Brazil Genomics Market by Technology
8.4.5.2 Argentina Genomics Market
8.4.5.2.1 Argentina Genomics Market by Product & Service
8.4.5.2.2 Argentina Genomics Market by Application
8.4.5.2.3 Argentina Genomics Market by End User
8.4.5.2.4 Argentina Genomics Market by Technology
8.4.5.3 UAE Genomics Market
8.4.5.3.1 UAE Genomics Market by Product & Service
8.4.5.3.2 UAE Genomics Market by Application
8.4.5.3.3 UAE Genomics Market by End User
8.4.5.3.4 UAE Genomics Market by Technology
8.4.5.4 Saudi Arabia Genomics Market
8.4.5.4.1 Saudi Arabia Genomics Market by Product & Service
8.4.5.4.2 Saudi Arabia Genomics Market by Application
8.4.5.4.3 Saudi Arabia Genomics Market by End User
8.4.5.4.4 Saudi Arabia Genomics Market by Technology
8.4.5.5 South Africa Genomics Market
8.4.5.5.1 South Africa Genomics Market by Product & Service
8.4.5.5.2 South Africa Genomics Market by Application
8.4.5.5.3 South Africa Genomics Market by End User
8.4.5.5.4 South Africa Genomics Market by Technology
8.4.5.6 Nigeria Genomics Market
8.4.5.6.1 Nigeria Genomics Market by Product & Service
8.4.5.6.2 Nigeria Genomics Market by Application
8.4.5.6.3 Nigeria Genomics Market by End User
8.4.5.6.4 Nigeria Genomics Market by Technology
8.4.5.7 Rest of LAMEA Genomics Market
8.4.5.7.1 Rest of LAMEA Genomics Market by Product & Service
8.4.5.7.2 Rest of LAMEA Genomics Market by Application
8.4.5.7.3 Rest of LAMEA Genomics Market by End User
8.4.5.7.4 Rest of LAMEA Genomics Market by Technology

Chapter 9. Company Profiles
9.1 Creative Biogene
9.1.1 Company Overview
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.10. New England BioLabs, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:

TABLE 1 Partnerships, Collaborations and Agreements– Genomics Market
TABLE 2 Product Launches And Product Expansions– Genomics Market
TABLE 3 Acquisition and Mergers– Genomics Market
TABLE 4 Global Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 5 Global Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 6 Global Consumables Market by Region, 2017 - 2020, USD Million
TABLE 7 Global Consumables Market by Region, 2021 - 2027, USD Million
TABLE 8 Global Systems & Software Market by Region, 2017 - 2020, USD Million
TABLE 9 Global Systems & Software Market by Region, 2021 - 2027, USD Million
TABLE 10 Global Services Market by Region, 2017 - 2020, USD Million
TABLE 11 Global Services Market by Region, 2021 - 2027, USD Million
TABLE 12 Global Genomics Market by Application , 2017 - 2020, USD Million
TABLE 13 Global Genomics Market by Application , 2021 - 2027, USD Million
TABLE 14 Global Drug Discovery & Development Market by Region, 2017 - 2020, USD Million
TABLE 15 Global Drug Discovery & Development Market by Region, 2021 - 2027, USD Million
TABLE 16 Global Diagnostics Market by Region, 2017 - 2020, USD Million
TABLE 17 Global Diagnostics Market by Region, 2021 - 2027, USD Million
TABLE 18 Global Agriculture & Animal Research Market by Region, 2017 - 2020, USD Million
TABLE 19 Global Agriculture & Animal Research Market by Region, 2021 - 2027, USD Million
TABLE 20 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 21 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 22 Global Genomics Market by End User, 2017 - 2020, USD Million
TABLE 23 Global Genomics Market by End User, 2021 - 2027, USD Million
TABLE 24 Global Hospitals & Clinics Market by Region, 2017 - 2020, USD Million
TABLE 25 Global Hospitals & Clinics Market by Region, 2021 - 2027, USD Million
TABLE 26 Global Research Centers and Academic & Government Institutes Market by Region, 2017 - 2020, USD Million
TABLE 27 Global Research Centers and Academic & Government Institutes Market by Region, 2021 - 2027, USD Million
TABLE 28 Global Pharmaceutical & Biotechnology Companies Market by Region, 2017 - 2020, USD Million
TABLE 29 Global Pharmaceutical & Biotechnology Companies Market by Region, 2021 - 2027, USD Million
TABLE 30 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 31 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 32 Global Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 33 Global Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 34 Global Sequencing Market by Region, 2017 - 2020, USD Million
TABLE 35 Global Sequencing Market by Region, 2021 - 2027, USD Million
TABLE 36 Global PCR Market by Region, 2017 - 2020, USD Million
TABLE 37 Global PCR Market by Region, 2021 - 2027, USD Million
TABLE 38 Global Nucleic Acid Extraction & Purification Market by Region, 2017 - 2020, USD Million
TABLE 39 Global Nucleic Acid Extraction & Purification Market by Region, 2021 - 2027, USD Million
TABLE 40 Global Microarray Market by Region, 2017 - 2020, USD Million
TABLE 41 Global Microarray Market by Region, 2021 - 2027, USD Million
TABLE 42 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 43 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 44 Global Genomics Market by Region, 2017 - 2020, USD Million
TABLE 45 Global Genomics Market by Region, 2021 - 2027, USD Million
TABLE 46 North America Genomics Market, 2017 - 2020, USD Million
TABLE 47 North America Genomics Market, 2021 - 2027, USD Million
TABLE 48 North America Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 49 North America Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 50 North America Consumables Market by Country, 2017 - 2020, USD Million
TABLE 51 North America Consumables Market by Country, 2021 - 2027, USD Million
TABLE 52 North America Systems & Software Market by Country, 2017 - 2020, USD Million
TABLE 53 North America Systems & Software Market by Country, 2021 - 2027, USD Million
TABLE 54 North America Services Market by Country, 2017 - 2020, USD Million
TABLE 55 North America Services Market by Country, 2021 - 2027, USD Million
TABLE 56 North America Genomics Market by Application , 2017 - 2020, USD Million
TABLE 57 North America Genomics Market by Application , 2021 - 2027, USD Million
TABLE 58 North America Drug Discovery & Development Market by Country, 2017 - 2020, USD Million
TABLE 59 North America Drug Discovery & Development Market by Country, 2021 - 2027, USD Million
TABLE 60 North America Diagnostics Market by Country, 2017 - 2020, USD Million
TABLE 61 North America Diagnostics Market by Country, 2021 - 2027, USD Million
TABLE 62 North America Agriculture & Animal Research Market by Country, 2017 - 2020, USD Million
TABLE 63 North America Agriculture & Animal Research Market by Country, 2021 - 2027, USD Million
TABLE 64 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 65 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 66 North America Genomics Market by End User, 2017 - 2020, USD Million
TABLE 67 North America Genomics Market by End User, 2021 - 2027, USD Million
TABLE 68 North America Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 69 North America Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 70 North America Research Centers and Academic & Government Institutes Market by Country, 2017 - 2020, USD Million
TABLE 71 North America Research Centers and Academic & Government Institutes Market by Country, 2021 - 2027, USD Million
TABLE 72 North America Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
TABLE 73 North America Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
TABLE 74 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 75 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 76 North America Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 77 North America Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 78 North America Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 79 North America Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 80 North America PCR Market by Country, 2017 - 2020, USD Million
TABLE 81 North America PCR Market by Country, 2021 - 2027, USD Million
TABLE 82 North America Nucleic Acid Extraction & Purification Market by Country, 2017 - 2020, USD Million
TABLE 83 North America Nucleic Acid Extraction & Purification Market by Country, 2021 - 2027, USD Million
TABLE 84 North America Microarray Market by Country, 2017 - 2020, USD Million
TABLE 85 North America Microarray Market by Country, 2021 - 2027, USD Million
TABLE 86 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 87 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 88 North America Genomics Market by Country, 2017 - 2020, USD Million
TABLE 89 North America Genomics Market by Country, 2021 - 2027, USD Million
TABLE 90 US Genomics Market, 2017 - 2020, USD Million
TABLE 91 US Genomics Market, 2021 - 2027, USD Million
TABLE 92 US Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 93 US Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 94 US Genomics Market by Application , 2017 - 2020, USD Million
TABLE 95 US Genomics Market by Application , 2021 - 2027, USD Million
TABLE 96 US Genomics Market by End User, 2017 - 2020, USD Million
TABLE 97 US Genomics Market by End User, 2021 - 2027, USD Million
TABLE 98 US Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 99 US Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 100 Canada Genomics Market, 2017 - 2020, USD Million
TABLE 101 Canada Genomics Market, 2021 - 2027, USD Million
TABLE 102 Canada Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 103 Canada Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 104 Canada Genomics Market by Application , 2017 - 2020, USD Million
TABLE 105 Canada Genomics Market by Application , 2021 - 2027, USD Million
TABLE 106 Canada Genomics Market by End User, 2017 - 2020, USD Million
TABLE 107 Canada Genomics Market by End User, 2021 - 2027, USD Million
TABLE 108 Canada Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 109 Canada Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 110 Mexico Genomics Market, 2017 - 2020, USD Million
TABLE 111 Mexico Genomics Market, 2021 - 2027, USD Million
TABLE 112 Mexico Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 113 Mexico Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 114 Mexico Genomics Market by Application , 2017 - 2020, USD Million
TABLE 115 Mexico Genomics Market by Application , 2021 - 2027, USD Million
TABLE 116 Mexico Genomics Market by End User, 2017 - 2020, USD Million
TABLE 117 Mexico Genomics Market by End User, 2021 - 2027, USD Million
TABLE 118 Mexico Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 119 Mexico Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 120 Rest of North America Genomics Market, 2017 - 2020, USD Million
TABLE 121 Rest of North America Genomics Market, 2021 - 2027, USD Million
TABLE 122 Rest of North America Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 123 Rest of North America Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 124 Rest of North America Genomics Market by Application , 2017 - 2020, USD Million
TABLE 125 Rest of North America Genomics Market by Application , 2021 - 2027, USD Million
TABLE 126 Rest of North America Genomics Market by End User, 2017 - 2020, USD Million
TABLE 127 Rest of North America Genomics Market by End User, 2021 - 2027, USD Million
TABLE 128 Rest of North America Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 129 Rest of North America Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 130 Europe Genomics Market, 2017 - 2020, USD Million
TABLE 131 Europe Genomics Market, 2021 - 2027, USD Million
TABLE 132 Europe Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 133 Europe Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 134 Europe Consumables Market by Country, 2017 - 2020, USD Million
TABLE 135 Europe Consumables Market by Country, 2021 - 2027, USD Million
TABLE 136 Europe Systems & Software Market by Country, 2017 - 2020, USD Million
TABLE 137 Europe Systems & Software Market by Country, 2021 - 2027, USD Million
TABLE 138 Europe Services Market by Country, 2017 - 2020, USD Million
TABLE 139 Europe Services Market by Country, 2021 - 2027, USD Million
TABLE 140 Europe Genomics Market by Application , 2017 - 2020, USD Million
TABLE 141 Europe Genomics Market by Application , 2021 - 2027, USD Million
TABLE 142 Europe Drug Discovery & Development Market by Country, 2017 - 2020, USD Million
TABLE 143 Europe Drug Discovery & Development Market by Country, 2021 - 2027, USD Million
TABLE 144 Europe Diagnostics Market by Country, 2017 - 2020, USD Million
TABLE 145 Europe Diagnostics Market by Country, 2021 - 2027, USD Million
TABLE 146 Europe Agriculture & Animal Research Market by Country, 2017 - 2020, USD Million
TABLE 147 Europe Agriculture & Animal Research Market by Country, 2021 - 2027, USD Million
TABLE 148 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 149 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 150 Europe Genomics Market by End User, 2017 - 2020, USD Million
TABLE 151 Europe Genomics Market by End User, 2021 - 2027, USD Million
TABLE 152 Europe Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 153 Europe Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 154 Europe Research Centers and Academic & Government Institutes Market by Country, 2017 - 2020, USD Million
TABLE 155 Europe Research Centers and Academic & Government Institutes Market by Country, 2021 - 2027, USD Million
TABLE 156 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
TABLE 157 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
TABLE 158 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 159 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 160 Europe Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 161 Europe Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 162 Europe Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 163 Europe Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 164 Europe PCR Market by Country, 2017 - 2020, USD Million
TABLE 165 Europe PCR Market by Country, 2021 - 2027, USD Million
TABLE 166 Europe Nucleic Acid Extraction & Purification Market by Country, 2017 - 2020, USD Million
TABLE 167 Europe Nucleic Acid Extraction & Purification Market by Country, 2021 - 2027, USD Million
TABLE 168 Europe Microarray Market by Country, 2017 - 2020, USD Million
TABLE 169 Europe Microarray Market by Country, 2021 - 2027, USD Million
TABLE 170 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 171 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 172 Europe Genomics Market by Country, 2017 - 2020, USD Million
TABLE 173 Europe Genomics Market by Country, 2021 - 2027, USD Million
TABLE 174 Germany Genomics Market, 2017 - 2020, USD Million
TABLE 175 Germany Genomics Market, 2021 - 2027, USD Million
TABLE 176 Germany Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 177 Germany Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 178 Germany Genomics Market by Application , 2017 - 2020, USD Million
TABLE 179 Germany Genomics Market by Application , 2021 - 2027, USD Million
TABLE 180 Germany Genomics Market by End User, 2017 - 2020, USD Million
TABLE 181 Germany Genomics Market by End User, 2021 - 2027, USD Million
TABLE 182 Germany Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 183 Germany Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 184 UK Genomics Market, 2017 - 2020, USD Million
TABLE 185 UK Genomics Market, 2021 - 2027, USD Million
TABLE 186 UK Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 187 UK Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 188 UK Genomics Market by Application , 2017 - 2020, USD Million
TABLE 189 UK Genomics Market by Application , 2021 - 2027, USD Million
TABLE 190 UK Genomics Market by End User, 2017 - 2020, USD Million
TABLE 191 UK Genomics Market by End User, 2021 - 2027, USD Million
TABLE 192 UK Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 193 UK Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 194 France Genomics Market, 2017 - 2020, USD Million
TABLE 195 France Genomics Market, 2021 - 2027, USD Million
TABLE 196 France Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 197 France Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 198 France Genomics Market by Application , 2017 - 2020, USD Million
TABLE 199 France Genomics Market by Application , 2021 - 2027, USD Million
TABLE 200 France Genomics Market by End User, 2017 - 2020, USD Million
TABLE 201 France Genomics Market by End User, 2021 - 2027, USD Million
TABLE 202 France Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 203 France Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 204 Russia Genomics Market, 2017 - 2020, USD Million
TABLE 205 Russia Genomics Market, 2021 - 2027, USD Million
TABLE 206 Russia Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 207 Russia Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 208 Russia Genomics Market by Application , 2017 - 2020, USD Million
TABLE 209 Russia Genomics Market by Application , 2021 - 2027, USD Million
TABLE 210 Russia Genomics Market by End User, 2017 - 2020, USD Million
TABLE 211 Russia Genomics Market by End User, 2021 - 2027, USD Million
TABLE 212 Russia Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 213 Russia Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 214 Spain Genomics Market, 2017 - 2020, USD Million
TABLE 215 Spain Genomics Market, 2021 - 2027, USD Million
TABLE 216 Spain Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 217 Spain Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 218 Spain Genomics Market by Application , 2017 - 2020, USD Million
TABLE 219 Spain Genomics Market by Application , 2021 - 2027, USD Million
TABLE 220 Spain Genomics Market by End User, 2017 - 2020, USD Million
TABLE 221 Spain Genomics Market by End User, 2021 - 2027, USD Million
TABLE 222 Spain Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 223 Spain Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 224 Italy Genomics Market, 2017 - 2020, USD Million
TABLE 225 Italy Genomics Market, 2021 - 2027, USD Million
TABLE 226 Italy Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 227 Italy Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 228 Italy Genomics Market by Application , 2017 - 2020, USD Million
TABLE 229 Italy Genomics Market by Application , 2021 - 2027, USD Million
TABLE 230 Italy Genomics Market by End User, 2017 - 2020, USD Million
TABLE 231 Italy Genomics Market by End User, 2021 - 2027, USD Million
TABLE 232 Italy Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 233 Italy Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 234 Rest of Europe Genomics Market, 2017 - 2020, USD Million
TABLE 235 Rest of Europe Genomics Market, 2021 - 2027, USD Million
TABLE 236 Rest of Europe Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 237 Rest of Europe Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 238 Rest of Europe Genomics Market by Application , 2017 - 2020, USD Million
TABLE 239 Rest of Europe Genomics Market by Application , 2021 - 2027, USD Million
TABLE 240 Rest of Europe Genomics Market by End User, 2017 - 2020, USD Million
TABLE 241 Rest of Europe Genomics Market by End User, 2021 - 2027, USD Million
TABLE 242 Rest of Europe Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 243 Rest of Europe Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 244 Asia Pacific Genomics Market, 2017 - 2020, USD Million
TABLE 245 Asia Pacific Genomics Market, 2021 - 2027, USD Million
TABLE 246 Asia Pacific Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 247 Asia Pacific Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 248 Asia Pacific Consumables Market by Country, 2017 - 2020, USD Million
TABLE 249 Asia Pacific Consumables Market by Country, 2021 - 2027, USD Million
TABLE 250 Asia Pacific Systems & Software Market by Country, 2017 - 2020, USD Million
TABLE 251 Asia Pacific Systems & Software Market by Country, 2021 - 2027, USD Million
TABLE 252 Asia Pacific Services Market by Country, 2017 - 2020, USD Million
TABLE 253 Asia Pacific Services Market by Country, 2021 - 2027, USD Million
TABLE 254 Asia Pacific Genomics Market by Application , 2017 - 2020, USD Million
TABLE 255 Asia Pacific Genomics Market by Application , 2021 - 2027, USD Million
TABLE 256 Asia Pacific Drug Discovery & Development Market by Country, 2017 - 2020, USD Million
TABLE 257 Asia Pacific Drug Discovery & Development Market by Country, 2021 - 2027, USD Million
TABLE 258 Asia Pacific Diagnostics Market by Country, 2017 - 2020, USD Million
TABLE 259 Asia Pacific Diagnostics Market by Country, 2021 - 2027, USD Million
TABLE 260 Asia Pacific Agriculture & Animal Research Market by Country, 2017 - 2020, USD Million
TABLE 261 Asia Pacific Agriculture & Animal Research Market by Country, 2021 - 2027, USD Million
TABLE 262 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 263 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 264 Asia Pacific Genomics Market by End User, 2017 - 2020, USD Million
TABLE 265 Asia Pacific Genomics Market by End User, 2021 - 2027, USD Million
TABLE 266 Asia Pacific Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 267 Asia Pacific Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 268 Asia Pacific Research Centers and Academic & Government Institutes Market by Country, 2017 - 2020, USD Million
TABLE 269 Asia Pacific Research Centers and Academic & Government Institutes Market by Country, 2021 - 2027, USD Million
TABLE 270 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
TABLE 271 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
TABLE 272 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 273 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 274 Asia Pacific Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 275 Asia Pacific Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 276 Asia Pacific Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 277 Asia Pacific Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 278 Asia Pacific PCR Market by Country, 2017 - 2020, USD Million
TABLE 279 Asia Pacific PCR Market by Country, 2021 - 2027, USD Million
TABLE 280 Asia Pacific Nucleic Acid Extraction & Purification Market by Country, 2017 - 2020, USD Million
TABLE 281 Asia Pacific Nucleic Acid Extraction & Purification Market by Country, 2021 - 2027, USD Million
TABLE 282 Asia Pacific Microarray Market by Country, 2017 - 2020, USD Million
TABLE 283 Asia Pacific Microarray Market by Country, 2021 - 2027, USD Million
TABLE 284 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 285 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 286 Asia Pacific Genomics Market by Country, 2017 - 2020, USD Million
TABLE 287 Asia Pacific Genomics Market by Country, 2021 - 2027, USD Million
TABLE 288 China Genomics Market, 2017 - 2020, USD Million
TABLE 289 China Genomics Market, 2021 - 2027, USD Million
TABLE 290 China Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 291 China Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 292 China Genomics Market by Application , 2017 - 2020, USD Million
TABLE 293 China Genomics Market by Application , 2021 - 2027, USD Million
TABLE 294 China Genomics Market by End User, 2017 - 2020, USD Million
TABLE 295 China Genomics Market by End User, 2021 - 2027, USD Million
TABLE 296 China Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 297 China Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 298 Japan Genomics Market, 2017 - 2020, USD Million
TABLE 299 Japan Genomics Market, 2021 - 2027, USD Million
TABLE 300 Japan Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 301 Japan Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 302 Japan Genomics Market by Application , 2017 - 2020, USD Million
TABLE 303 Japan Genomics Market by Application , 2021 - 2027, USD Million
TABLE 304 Japan Genomics Market by End User, 2017 - 2020, USD Million
TABLE 305 Japan Genomics Market by End User, 2021 - 2027, USD Million
TABLE 306 Japan Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 307 Japan Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 308 India Genomics Market, 2017 - 2020, USD Million
TABLE 309 India Genomics Market, 2021 - 2027, USD Million
TABLE 310 India Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 311 India Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 312 India Genomics Market by Application , 2017 - 2020, USD Million
TABLE 313 India Genomics Market by Application , 2021 - 2027, USD Million
TABLE 314 India Genomics Market by End User, 2017 - 2020, USD Million
TABLE 315 India Genomics Market by End User, 2021 - 2027, USD Million
TABLE 316 India Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 317 India Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 318 South Korea Genomics Market, 2017 - 2020, USD Million
TABLE 319 South Korea Genomics Market, 2021 - 2027, USD Million
TABLE 320 South Korea Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 321 South Korea Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 322 South Korea Genomics Market by Application , 2017 - 2020, USD Million
TABLE 323 South Korea Genomics Market by Application , 2021 - 2027, USD Million
TABLE 324 South Korea Genomics Market by End User, 2017 - 2020, USD Million
TABLE 325 South Korea Genomics Market by End User, 2021 - 2027, USD Million
TABLE 326 South Korea Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 327 South Korea Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 328 Singapore Genomics Market, 2017 - 2020, USD Million
TABLE 329 Singapore Genomics Market, 2021 - 2027, USD Million
TABLE 330 Singapore Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 331 Singapore Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 332 Singapore Genomics Market by Application , 2017 - 2020, USD Million
TABLE 333 Singapore Genomics Market by Application , 2021 - 2027, USD Million
TABLE 334 Singapore Genomics Market by End User, 2017 - 2020, USD Million
TABLE 335 Singapore Genomics Market by End User, 2021 - 2027, USD Million
TABLE 336 Singapore Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 337 Singapore Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 338 Malaysia Genomics Market, 2017 - 2020, USD Million
TABLE 339 Malaysia Genomics Market, 2021 - 2027, USD Million
TABLE 340 Malaysia Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 341 Malaysia Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 342 Malaysia Genomics Market by Application , 2017 - 2020, USD Million
TABLE 343 Malaysia Genomics Market by Application , 2021 - 2027, USD Million
TABLE 344 Malaysia Genomics Market by End User, 2017 - 2020, USD Million
TABLE 345 Malaysia Genomics Market by End User, 2021 - 2027, USD Million
TABLE 346 Malaysia Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 347 Malaysia Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 348 Rest of Asia Pacific Genomics Market, 2017 - 2020, USD Million
TABLE 349 Rest of Asia Pacific Genomics Market, 2021 - 2027, USD Million
TABLE 350 Rest of Asia Pacific Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 351 Rest of Asia Pacific Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 352 Rest of Asia Pacific Genomics Market by Application , 2017 - 2020, USD Million
TABLE 353 Rest of Asia Pacific Genomics Market by Application , 2021 - 2027, USD Million
TABLE 354 Rest of Asia Pacific Genomics Market by End User, 2017 - 2020, USD Million
TABLE 355 Rest of Asia Pacific Genomics Market by End User, 2021 - 2027, USD Million
TABLE 356 Rest of Asia Pacific Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 357 Rest of Asia Pacific Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 358 LAMEA Genomics Market, 2017 - 2020, USD Million
TABLE 359 LAMEA Genomics Market, 2021 - 2027, USD Million
TABLE 360 LAMEA Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 361 LAMEA Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 362 LAMEA Consumables Market by Country, 2017 - 2020, USD Million
TABLE 363 LAMEA Consumables Market by Country, 2021 - 2027, USD Million
TABLE 364 LAMEA Systems & Software Market by Country, 2017 - 2020, USD Million
TABLE 365 LAMEA Systems & Software Market by Country, 2021 - 2027, USD Million
TABLE 366 LAMEA Services Market by Country, 2017 - 2020, USD Million
TABLE 367 LAMEA Services Market by Country, 2021 - 2027, USD Million
TABLE 368 LAMEA Genomics Market by Application , 2017 - 2020, USD Million
TABLE 369 LAMEA Genomics Market by Application , 2021 - 2027, USD Million
TABLE 370 LAMEA Drug Discovery & Development Market by Country, 2017 - 2020, USD Million
TABLE 371 LAMEA Drug Discovery & Development Market by Country, 2021 - 2027, USD Million
TABLE 372 LAMEA Diagnostics Market by Country, 2017 - 2020, USD Million
TABLE 373 LAMEA Diagnostics Market by Country, 2021 - 2027, USD Million
TABLE 374 LAMEA Agriculture & Animal Research Market by Country, 2017 - 2020, USD Million
TABLE 375 LAMEA Agriculture & Animal Research Market by Country, 2021 - 2027, USD Million
TABLE 376 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 377 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 378 LAMEA Genomics Market by End User, 2017 - 2020, USD Million
TABLE 379 LAMEA Genomics Market by End User, 2021 - 2027, USD Million
TABLE 380 LAMEA Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 381 LAMEA Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 382 LAMEA Research Centers and Academic & Government Institutes Market by Country, 2017 - 2020, USD Million
TABLE 383 LAMEA Research Centers and Academic & Government Institutes Market by Country, 2021 - 2027, USD Million
TABLE 384 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2017 - 2020, USD Million
TABLE 385 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2021 - 2027, USD Million
TABLE 386 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 387 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 388 LAMEA Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 389 LAMEA Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 390 LAMEA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 391 LAMEA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 392 LAMEA PCR Market by Country, 2017 - 2020, USD Million
TABLE 393 LAMEA PCR Market by Country, 2021 - 2027, USD Million
TABLE 394 LAMEA Nucleic Acid Extraction & Purification Market by Country, 2017 - 2020, USD Million
TABLE 395 LAMEA Nucleic Acid Extraction & Purification Market by Country, 2021 - 2027, USD Million
TABLE 396 LAMEA Microarray Market by Country, 2017 - 2020, USD Million
TABLE 397 LAMEA Microarray Market by Country, 2021 - 2027, USD Million
TABLE 398 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 399 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 400 LAMEA Genomics Market by Country, 2017 - 2020, USD Million
TABLE 401 LAMEA Genomics Market by Country, 2021 - 2027, USD Million
TABLE 402 Brazil Genomics Market, 2017 - 2020, USD Million
TABLE 403 Brazil Genomics Market, 2021 - 2027, USD Million
TABLE 404 Brazil Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 405 Brazil Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 406 Brazil Genomics Market by Application , 2017 - 2020, USD Million
TABLE 407 Brazil Genomics Market by Application , 2021 - 2027, USD Million
TABLE 408 Brazil Genomics Market by End User, 2017 - 2020, USD Million
TABLE 409 Brazil Genomics Market by End User, 2021 - 2027, USD Million
TABLE 410 Brazil Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 411 Brazil Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 412 Argentina Genomics Market, 2017 - 2020, USD Million
TABLE 413 Argentina Genomics Market, 2021 - 2027, USD Million
TABLE 414 Argentina Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 415 Argentina Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 416 Argentina Genomics Market by Application , 2017 - 2020, USD Million
TABLE 417 Argentina Genomics Market by Application , 2021 - 2027, USD Million
TABLE 418 Argentina Genomics Market by End User, 2017 - 2020, USD Million
TABLE 419 Argentina Genomics Market by End User, 2021 - 2027, USD Million
TABLE 420 Argentina Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 421 Argentina Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 422 UAE Genomics Market, 2017 - 2020, USD Million
TABLE 423 UAE Genomics Market, 2021 - 2027, USD Million
TABLE 424 UAE Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 425 UAE Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 426 UAE Genomics Market by Application , 2017 - 2020, USD Million
TABLE 427 UAE Genomics Market by Application , 2021 - 2027, USD Million
TABLE 428 UAE Genomics Market by End User, 2017 - 2020, USD Million
TABLE 429 UAE Genomics Market by End User, 2021 - 2027, USD Million
TABLE 430 UAE Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 431 UAE Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 432 Saudi Arabia Genomics Market, 2017 - 2020, USD Million
TABLE 433 Saudi Arabia Genomics Market, 2021 - 2027, USD Million
TABLE 434 Saudi Arabia Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 435 Saudi Arabia Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 436 Saudi Arabia Genomics Market by Application , 2017 - 2020, USD Million
TABLE 437 Saudi Arabia Genomics Market by Application , 2021 - 2027, USD Million
TABLE 438 Saudi Arabia Genomics Market by End User, 2017 - 2020, USD Million
TABLE 439 Saudi Arabia Genomics Market by End User, 2021 - 2027, USD Million
TABLE 440 Saudi Arabia Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 441 Saudi Arabia Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 442 South Africa Genomics Market, 2017 - 2020, USD Million
TABLE 443 South Africa Genomics Market, 2021 - 2027, USD Million
TABLE 444 South Africa Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 445 South Africa Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 446 South Africa Genomics Market by Application , 2017 - 2020, USD Million
TABLE 447 South Africa Genomics Market by Application , 2021 - 2027, USD Million
TABLE 448 South Africa Genomics Market by End User, 2017 - 2020, USD Million
TABLE 449 South Africa Genomics Market by End User, 2021 - 2027, USD Million
TABLE 450 South Africa Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 451 South Africa Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 452 Nigeria Genomics Market, 2017 - 2020, USD Million
TABLE 453 Nigeria Genomics Market, 2021 - 2027, USD Million
TABLE 454 Nigeria Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 455 Nigeria Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 456 Nigeria Genomics Market by Application , 2017 - 2020, USD Million
TABLE 457 Nigeria Genomics Market by Application , 2021 - 2027, USD Million
TABLE 458 Nigeria Genomics Market by End User, 2017 - 2020, USD Million
TABLE 459 Nigeria Genomics Market by End User, 2021 - 2027, USD Million
TABLE 460 Nigeria Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 461 Nigeria Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 462 Rest of LAMEA Genomics Market, 2017 - 2020, USD Million
TABLE 463 Rest of LAMEA Genomics Market, 2021 - 2027, USD Million
TABLE 464 Rest of LAMEA Genomics Market by Product & Service, 2017 - 2020, USD Million
TABLE 465 Rest of LAMEA Genomics Market by Product & Service, 2021 - 2027, USD Million
TABLE 466 Rest of LAMEA Genomics Market by Application , 2017 - 2020, USD Million
TABLE 467 Rest of LAMEA Genomics Market by Application , 2021 - 2027, USD Million
TABLE 468 Rest of LAMEA Genomics Market by End User, 2017 - 2020, USD Million
TABLE 469 Rest of LAMEA Genomics Market by End User, 2021 - 2027, USD Million
TABLE 470 Rest of LAMEA Genomics Market by Technology, 2017 - 2020, USD Million
TABLE 471 Rest of LAMEA Genomics Market by Technology, 2021 - 2027, USD Million
TABLE 472 Key Information – Creative Biogene
TABLE 473 Key Information – Thermo Fisher Scientific, Inc.
TABLE 474 key information – Illumina, Inc.
TABLE 475 Key Information – Bio-Rad Laboratories, Inc.
TABLE 476 Key Information – Danaher Corporation
TABLE 477 key Information – Agilent Technologies, Inc.
TABLE 478 key information – F. Hoffmann-La Roche Ltd.
TABLE 479 Key Information – Eurofins Scientific Group
TABLE 480 Key Information –Qiagen N.V.
TABLE 481 Key Information – New England BioLabs, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, dec) Leading Players
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Recent strategies and developments: Illumina, Inc.
FIG 7 Recent strategies and developments: Bio-Rad laboratories, Inc.
FIG 8 Recent strategies and developments: Agilent Technologies, Inc.
FIG 9 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 10 Recent strategies and developments: Qiagen N.V.